[go: up one dir, main page]

IT1193190B - 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito - Google Patents

2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito

Info

Publication number
IT1193190B
IT1193190B IT24165/79A IT2416579A IT1193190B IT 1193190 B IT1193190 B IT 1193190B IT 24165/79 A IT24165/79 A IT 24165/79A IT 2416579 A IT2416579 A IT 2416579A IT 1193190 B IT1193190 B IT 1193190B
Authority
IT
Italy
Prior art keywords
tetraidro
benzazepine
mercapto
replaced
benzazepine mercapto
Prior art date
Application number
IT24165/79A
Other languages
English (en)
Other versions
IT7924165A0 (it
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of IT7924165A0 publication Critical patent/IT7924165A0/it
Application granted granted Critical
Publication of IT1193190B publication Critical patent/IT1193190B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IT24165/79A 1978-07-07 1979-07-06 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito IT1193190B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92261378A 1978-07-07 1978-07-07

Publications (2)

Publication Number Publication Date
IT7924165A0 IT7924165A0 (it) 1979-07-06
IT1193190B true IT1193190B (it) 1988-06-02

Family

ID=25447325

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24165/79A IT1193190B (it) 1978-07-07 1979-07-06 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito

Country Status (24)

Country Link
EP (2) EP0007070B1 (it)
JP (1) JPS5511584A (it)
AR (1) AR222828A1 (it)
AU (1) AU525789B2 (it)
CA (1) CA1115271A (it)
CS (1) CS213381B2 (it)
DD (1) DD147355A5 (it)
DE (1) DE2964530D1 (it)
DK (1) DK156001C (it)
ES (3) ES482282A1 (it)
FI (1) FI67215C (it)
GR (1) GR69675B (it)
HU (1) HU179315B (it)
IE (1) IE48654B1 (it)
IL (1) IL57532A (it)
IT (1) IT1193190B (it)
JO (1) JO1273B1 (it)
NO (1) NO152213C (it)
NZ (1) NZ190745A (it)
PH (1) PH15754A (it)
PL (1) PL216908A1 (it)
PT (1) PT69855A (it)
SU (1) SU1029827A3 (it)
ZA (1) ZA792785B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4652642A (en) * 1984-08-23 1987-03-24 Smithkline Beckman Corporation Azidobenzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
DE69929704T2 (de) * 1998-10-08 2006-07-20 Smithkline Beecham Plc, Brentford Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
WO2004031181A1 (en) * 2002-10-07 2004-04-15 Glaxo Group Limited Sulfonamide derivatives as antipsychotic agents
EP2332919A3 (en) 2003-06-17 2011-10-19 Arena Pharmaceuticals, Inc. Processes for preparing 3-benzazepines
WO2005003096A1 (en) 2003-06-17 2005-01-13 Arena Pharmaceuticals, Inc. Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
KR100848411B1 (ko) * 2004-02-25 2008-07-28 일라이 릴리 앤드 캄파니 5-ht2c 수용체 아고니스트로서 6-치환된2,3,4,5-테트라히드로-1h-벤조[d]아제핀
ES2332009T3 (es) 2004-12-21 2010-01-22 Arena Pharmaceuticals, Inc. Formas cristalinas de hidrocloruro de (r)-8-cloro-1-metil-2,3,4,5-tetrahidro-1h-3-benzazepina.
EA015012B1 (ru) 2004-12-23 2011-04-29 Арена Фармасьютикалз, Инк. Композиция, содержащая фентермин и избирательный агонист рецептора 5ht, и ее применение
EP2471779A1 (en) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
SG177128A1 (en) 2006-12-05 2012-01-30 Arena Pharm Inc Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
US8822727B2 (en) 2008-03-04 2014-09-02 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
EA201390335A1 (ru) 2010-09-01 2013-09-30 Арена Фармасьютикалз, Инк. Введение лоркасерина индивидуумам с почечной недостаточностью
CN103189360A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的非吸湿性盐
AU2011296014A1 (en) 2010-09-01 2013-04-04 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AU2011296003B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonist useful for weight management
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520264A (en) * 1947-08-26 1950-08-29 Maltbie Lab Inc Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
US3483185A (en) 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
US3671519A (en) 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3752892A (en) 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US3716639A (en) 1970-03-11 1973-02-13 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepines
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4108989A (en) * 1977-04-01 1978-08-22 Smithkline Corporation 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones

Also Published As

Publication number Publication date
JPS5511584A (en) 1980-01-26
NO152213C (no) 1985-08-28
ES482281A1 (es) 1980-04-01
DK278379A (da) 1980-01-08
IE791276L (en) 1980-01-07
NO792267L (no) 1980-01-08
FI792125A7 (fi) 1980-01-08
EP0080012A1 (en) 1983-06-01
PT69855A (en) 1979-08-01
FI67215B (fi) 1984-10-31
ES482276A1 (es) 1980-04-01
SU1029827A3 (ru) 1983-07-15
JPH0153271B2 (it) 1989-11-13
EP0007070B1 (en) 1983-01-19
AU525789B2 (en) 1982-12-02
CS213381B2 (en) 1982-04-09
DK156001B (da) 1989-06-12
NZ190745A (en) 1981-01-23
EP0007070A1 (en) 1980-01-23
DD147355A5 (de) 1981-04-01
GR69675B (it) 1982-07-07
IT7924165A0 (it) 1979-07-06
HU179315B (en) 1982-09-28
PH15754A (en) 1983-03-18
NO152213B (no) 1985-05-13
CA1115271A (en) 1981-12-29
ES482282A1 (es) 1980-04-01
PL216908A1 (it) 1980-08-11
JO1273B1 (en) 1986-11-30
IL57532A (en) 1982-08-31
IE48654B1 (en) 1985-04-03
AR222828A1 (es) 1981-06-30
IL57532A0 (en) 1979-10-31
AU4861379A (en) 1980-02-07
DE2964530D1 (en) 1983-02-24
DK156001C (da) 1989-11-06
EP0080012B1 (en) 1986-04-09
ZA792785B (en) 1980-08-27
FI67215C (fi) 1985-02-11

Similar Documents

Publication Publication Date Title
NL7903029A (nl) 2'deoxy-5-(2-halogeenvinyl)-uridines.
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
DK537780A (da) 1,8-naphthyridin-derivater
NO153847C (no) 2,4,4-triklor-4-formyl-butyronitril.
FI792769A7 (fi) 3,4,5-trihydroxipiperidinderivat
FI793663A7 (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE7803411L (sv) 2,6-dialkoxibensamider
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
TR20548A (tr) 1,2,3-tiyadiyazel-5-yil uerelerin imalline mahsus usul
FI803727L (fi) 2,3-indolidionderivat
DK429179A (da) 2-propyl-pent-4-en-1-al.
ATA457479A (de) Stabilisietes 1,1,1-trichloraethan
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
ATA457579A (de) Stabilisiertes 1,1,1-trichloraethan
NO793639L (no) Fortoeyningsanordning.
FI801473A7 (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
NL7900005A (nl) 11-alkanoyl-4"-desoxy-4"-isonitrilo-oleandomycine-deri- vaten.
BE883295A (fr) 6,7-secoergolines
FI792770A7 (fi) Foerfarande foer framstaellning av 1,2,3-tiadiazol-5-ylkarbamider
FI793526A7 (fi) Foerfarande foer framstaellning av 5-merkapto-1,2,3-triazoler
DK136379A (da) 4,6-dihalogensteroider
FI792436A7 (fi) Foerfarande foer tillverkning av 7,8-diklortetrahydroisokinolin
DK430479A (da) 2,6-dihalogenbensylestere